Références

[1] Savovic J, Turner RM, Mawdsley D, et al. Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study. Am J Epidemiol 2018;187:1113–22 10.1093/aje/kwx344 [29126260]

[2] Sterne JAC, Jüni P, Schulz KF, et al. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological'research. Stat Med 2002;21:1513–24 10.1002/sim.1184 [12111917]

[3] Balk EM, Bonis PAL, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002;287:2973–82 10.1001/jama.287.22.2973 [12052127]

[4] Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–12 10.1001/jama.273.5.408 [7823387]

[5] Savović J, Jones H, Altman D, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess 2012;16:1–82 10.3310/hta16350 [22989478]

[6] Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? The Lancet 1998;352:609–13 10.1016/S0140-6736(98)01085-X

[7] Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898 10.1136/bmj.l4898 [31462531]

[8] Senn S. Testing for baseline balance in clinical trials. Stat Med 1994;13:1715–26 ; [7997705]